Impact of Yangzheng Xiaoji on the adhesion and migration of human cancer cells: The role of the AKT signalling pathway

Anticancer Research

Volumn 32, Issue 7, 2012, Pages 2537-2544

  Ye, Lin ^a   Ji, Ke ^a   Frewer, Natasha ^a   Ji, Jiafu ^a,b   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

AKT; Cancer cells; Cell adhesion; Cellular migration; ECIS; Osteosarcoma; PI3K; Prostate cancer; Signal transduction pathways

Indexed keywords

CHINESE DRUG; DME 25; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; UNCLASSIFIED DRUG; WORTMANNIN; YANGZHENG XIAOJI;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL STRAIN MCF 7; CHINESE MEDICINE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG FORMULATION; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CANCER; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; TRADITIONAL MEDICINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL ADHESION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; HUMANS; NEOPLASMS; ONCOGENE PROTEIN V-AKT; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84865677918     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kang SH, Jeong SJ, Kim SH, Kim JH, Jung JH, Koh W, Kim DK and Chen CY: Icariside II Induces Apoptosis in U937 Acute Myeloid Leukemia Cells: Role of Inactivation of STAT3-Related Signaling. PLoS One 7: e28706, 2012.
2. Zhang SY GC, Gao XD, Wu YL: A randomly double-blinded and multicentre study of chemotherapy assisted Yangzhengxiaoji capsule on treating primary hepatic carcinoma. J Diffic Compl Case 8: 461-464, 2009 (in Chinese).
3. Wang QL XC, Wu XP, Li YX and Bi XJ: Treatment of atypical gastric dysplasia using Yangzheng Xiaoji. Chin J Diffic Compl Case 2: 38-39 2008 (in Chinese).
4. Wani MC, Taylor HL, Wall ME, Coggon P and McPhail AT: Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
5. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H and Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557, 1990.
6. He R, Mott BT, Rosenthal AS, Genna DT, Posner GH and Arav-Boger R: An artemisinin-derived dimer has highly potent anticytomegalovirus (CMV) and anti-cancer activities. PLoS One 6: e24334, 2011.
7. Firestone GL and Sundar SN: Anticancer activities of artemisinin and its bioactive derivatives. Expert Rev Mol Med 11: e32, 2009.
8. Lai H, Nakase I, Lacoste E, Singh NP and Sasaki T: Artemisinin transferrin conjugate retards growth of breast tumors in the rat. Anticancer Res 29: 3807-3810, 2009.
9. Sun WC, Han JX, Yang WY, Deng DA and Yue XF: Antitumor activities of 4 derivatives of artemisic acid and artemisinin B in vitro. Zhongguo Yao Li Xue Bao 13: 541-543, 1992 (in Chinese).
10. Ye L, Ji K, Ji J, Hargest R and Jiang WG: Application of Electric Cell-Substrate Impedance Sensing in evaluation of traditional medicine on the cellular functions of gastric and colorecctal cancer cells. Cancer Metastasis Biol Treat, 2012, 17, in press.
11. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Scott C and Puntis MCA: Inhibition of invasion and motility of human colon cancer cells by gamma linolenic acid. Br J Cancer 71: 744-752, 1995.
12. Jiang WG, Hiscox SE, Parr C, Martin TA, Matsumoto K, Nakamura T and Mansel RE: Antagonistic effect of NK4, a novel hepatocyte growth factor variant, on in vitro angiogenesis of human vascular endothelial cells. Cancer Res 5: 3695-3703, 1999.
13. Giaever I and Keese CR: Micromotion of mammalian cells measured electrically. Proc. Natl Acad Sci USA 88: 7896-7900, 1991.
14. Jiang WG, Ablin RJ, Kynaston HG and Mason MD: The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway. Microvasc Res 77: 150-157, 2009.
15. Keese CR, Wegener J, Walker SR and Giaever I: Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA 101: 1554-1559, 2004.
16. Li L, Xia Y, Wang Z, Cao X, Da Z, Guo G, Qian J, Liu X, Fan Y, Sun L, Sang A and Gu Z: Suppression of the PI3K-Akt pathway is involved in the decreased adhesion and migration of bone marrow-derived mesenchymal stem cells from non-obese diabetic mice. Cell Biol Int 35: 961-966, 2011.
17. Lee YC, Cheng TH, Lee JS, Chen JH, Liao YC, Fong Y, Wu CH and Shih YW: Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Mol Cell Biochem 347: 103-115, 2011.
18. Thamilselvan V, Craig DH and Basson MD: FAK association with multiple signal proteins mediates pressure-induced colon cancer cell adhesion via a Src-dependent PI3K/Akt pathway. FASEB J 21: 1730-1741, 2007.
19. Ayral-Kaloustian S, Gu J, Lucas J, Cinque M, Gaydos C, Zask A, Chaudhary I, Wang J, Di L, Young M, Ruppen M, Mansour TS, Gibbons JJ and Yu K: Hybrid inhibitors of phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR): design, synthesis, and superior antitumor activity of novel wortmannin-rapamycin conjugates. J Med Chem 53: 452-459, 2010.
20. Wu Q, Chen Y, Cui G and Cheng Y: Wortmannin inhibits K562 leukemic cells by regulating PI3k/Akt channel in vitro . J Huazhong Univ Sci Technolog Med Sci 29: 451-456, 2009.
21. Zhang F, Zhang T, Jiang T, Zhang R, Teng ZH, Li C, Gu ZP and Mei Q: Wortmannin potentiates roscovitine-induced growth inhibition in human solid tumor cells by repressing PI3K/Akt pathway. Cancer Lett 286: 232-239, 2009.